4:03PM ISTA Pharm beats by $0.05, beats on revs; guides FY11 EPS below consensus, revs in-line (ISTA) 7.14 -0.08 : Reports Q4 (Dec) earnings of $0.14 per share, $0.05 better than the Thomson Reuters consensus of $0.09; revenues rose 49.4% year/year to $51.1 mln vs the $46.8 mln consensus. Co issues mixed guidance for FY11, sees EPS of $0.11-0.18 vs. $0.19 Thomson Reuters consensus; sees FY11 revs of $175-190 mln vs. $180.23 mln Thomson Reuters consensus.